Literature DB >> 21037130

The use of a series of ketamine infusions in two patients with treatment-resistant depression.

Michael Messer1, Irina V Haller, Pamela Larson, Julia Pattison-Crisostomo, Charles E Gessert.   

Abstract

Treatment-resistant depression often leads to increased morbidity and disability. The authors report the use of ketamine, a selective N-methyl-D-aspartate (NMDA) receptor antagonist, in two patients with treatment-resistant depression. Multiple ketamine treatments may provide an effective rapid antidepressant effect with prolonged benefit.

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 21037130     DOI： 10.1176/jnp.2010.22.4.442

Source DB:  PubMed          Journal:  J Neuropsychiatry Clin Neurosci        ISSN： 0895-0172            Impact factor:   2.198


  16 in total

Review 1.  Ketamine for depression: where do we go from here?

Authors:  Marije Aan Het Rot; Carlos A Zarate; Dennis S Charney; Sanjay J Mathew
Journal:  Biol Psychiatry       Date:  2012-06-16       Impact factor: 13.382

Review 2.  Glutamate receptor antagonists as fast-acting therapeutic alternatives for the treatment of depression: ketamine and other compounds.

Authors:  Mark J Niciu; Ioline D Henter; David A Luckenbaugh; Carlos A Zarate; Dennis S Charney
Journal:  Annu Rev Pharmacol Toxicol       Date:  2014       Impact factor: 13.820

Review 3.  Ketamine and Beyond: Investigations into the Potential of Glutamatergic Agents to Treat Depression.

Authors:  Marc S Lener; Bashkim Kadriu; Carlos A Zarate
Journal:  Drugs       Date:  2017-03       Impact factor: 9.546

4.  Do the dissociative side effects of ketamine mediate its antidepressant effects?

Authors:  David A Luckenbaugh; Mark J Niciu; Dawn F Ionescu; Neal M Nolan; Erica M Richards; Nancy E Brutsche; Sara Guevara; Carlos A Zarate
Journal:  J Affect Disord       Date:  2014-02-18       Impact factor: 4.839

Review 5.  Glutamate and its receptors in the pathophysiology and treatment of major depressive disorder.

Authors:  Mark J Niciu; Dawn F Ionescu; Erica M Richards; Carlos A Zarate
Journal:  J Neural Transm (Vienna)       Date:  2013-12-08       Impact factor: 3.575

6.  Clinically favourable effects of ketamine as an anaesthetic for electroconvulsive therapy: a retrospective study.

Authors:  Laura Kranaster; Jutta Kammerer-Ciernioch; Carolin Hoyer; Alexander Sartorius
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2011-03-13       Impact factor: 5.270

7.  Ketamine Therapy for Treatment-resistant Depression in a Patient with Multiple Sclerosis: A Case Report.

Authors:  Michael M Messer; Irina V Haller
Journal:  Innov Clin Neurosci       Date:  2017-02-01

8.  Failed response to repeat intravenous ketamine infusions in geriatric patients with major depressive disorder.

Authors:  Sarah M Szymkowicz; Nora Finnegan; Roman M Dale
Journal:  J Clin Psychopharmacol       Date:  2014-04       Impact factor: 3.153

Review 9.  Glutamate and Gamma-Aminobutyric Acid Systems in the Pathophysiology of Major Depression and Antidepressant Response to Ketamine.

Authors:  Marc S Lener; Mark J Niciu; Elizabeth D Ballard; Minkyung Park; Lawrence T Park; Allison C Nugent; Carlos A Zarate
Journal:  Biol Psychiatry       Date:  2016-05-12       Impact factor: 13.382

10.  A 12-month naturalistic observation of three patients receiving repeat intravenous ketamine infusions for their treatment-resistant depression.

Authors:  Sarah M Szymkowicz; Nora Finnegan; Roman M Dale
Journal:  J Affect Disord       Date:  2012-11-22       Impact factor: 4.839
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.